My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pfizer (NY:PFE)

26.43 +0.58 (+2.24%)

Official Closing Price Updated: 4:10 PM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock ↗

June 17, 2025

Via The Motley Fool

Topics Intellectual Property

3 Unprofitable Stocks with Mounting Challenges

June 17, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

1 S&P 500 Stock to Keep an Eye On and 2 to Steer Clear Of

June 16, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased ↗

June 13, 2025

Jefferies thinks big pharma companies are "still on the hunt" for deals.

Via Stocktwits

What's going on in today's session: S&P500 most active stocks ↗

June 13, 2025

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up ↗

June 13, 2025

The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.

Via Benzinga

3 Healthcare Stocks with Questionable Fundamentals

June 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.’s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)

June 12, 2025

From Berger Montague

Via GlobeNewswire

Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. ↗

June 12, 2025

Stay informed about the most active stocks in the S&P500 index on Thursday's session. Discover the stocks that are generating the highest trading volume and driving market activity.

Via Chartmill

BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment ↗

June 12, 2025

Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.

Via Stocktwits

Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5% ↗

June 12, 2025

Via The Motley Fool

RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Report ↗

June 12, 2025

Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices.

Via Benzinga

Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences

June 11, 2025

EQNX::TICKER_START (NNASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NASDAQ:BNTX),(NASDAQ:ARVN),(NYSE:PFE),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

June 11, 2025

Steady growth and dividend increases over decades can make investors remarkably wealthy.

Via The Motley Fool

Topics Economy

Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences

June 11, 2025

From FN Media Group LLC

Via GlobeNewswire

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia ↗

June 10, 2025

Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment.

Via Investor's Business Daily

2 Weight Loss Drug Stocks That Are Screaming Buys in June ↗

June 10, 2025

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

Via The Motley Fool

Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading ↗

June 10, 2025

A sweeping overhaul of the CDC's top vaccine advisory panel is ripping through the medical world, while rattling pharma and biotech stocks.

Via Benzinga

Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines? ↗

June 10, 2025

Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust."

Via Stocktwits

Topics Government

Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. ↗

June 09, 2025

A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition.

Via Investor's Business Daily

Topics Government

Metsera Stock Climbs On Positive Results From Early Stage Trial For Investigational Weight-Loss Drug: Retail Chatter Explodes ↗

June 09, 2025

The company said that the drug, MET-233i, demonstrated up to 8.4% mean placebo-subtracted weight loss at day 36.

Via Stocktwits

Topics Government

These S&P500 stocks are the most active in today's session ↗

June 09, 2025

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

Pfizer CEO Reportedly Says Company Made No Drug Price Pledges In Meeting With Trump Administration: Retail Sentiment Improves ↗

June 09, 2025

The meeting follows an executive order from President Trump last month, which directed drugmakers to lower medicine prices to the levels paid by other high-income countries.

Via Stocktwits

Topics Artificial Intelligence Government

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗

June 09, 2025

Via Benzinga

3 Stocks With Mouthwatering Dividends You Can Buy Right Now ↗

June 08, 2025

Via The Motley Fool

Topics Intellectual Property

Should You Buy Pfizer Stock Right Now? ↗

June 07, 2025

Via The Motley Fool

Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval ↗

June 06, 2025

Arvinas and Pfizer submit NDA to FDA for vepdegestrant after Phase 3 data shows efficacy in ESR1-mutated ER+/HER2- breast cancer patients

Via Benzinga

RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts ↗

June 06, 2025

U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health...

Via Benzinga

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

June 06, 2025

From Arvinas Inc.

Via GlobeNewswire

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis ↗

June 05, 2025

Via The Motley Fool

Topics Intellectual Property Retirement

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.